AU2206499A - Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions - Google Patents

Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions

Info

Publication number
AU2206499A
AU2206499A AU22064/99A AU2206499A AU2206499A AU 2206499 A AU2206499 A AU 2206499A AU 22064/99 A AU22064/99 A AU 22064/99A AU 2206499 A AU2206499 A AU 2206499A AU 2206499 A AU2206499 A AU 2206499A
Authority
AU
Australia
Prior art keywords
myopia
conditions
various
treat glaucoma
muscarinic agents
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22064/99A
Inventor
Thomas R. Dean
Mark R Hellberg
Andrew Hoffman
Abdelmoula Namil
Bryon S. Severns
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alcon Vision LLC
Original Assignee
Alcon Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Laboratories Inc filed Critical Alcon Laboratories Inc
Publication of AU2206499A publication Critical patent/AU2206499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56—Nitrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU22064/99A 1997-12-23 1998-12-22 Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions Abandoned AU2206499A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6862697P 1997-12-23 1997-12-23
US60068626 1997-12-23
PCT/US1998/027586 WO1999032443A1 (en) 1997-12-23 1998-12-22 Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions

Publications (1)

Publication Number Publication Date
AU2206499A true AU2206499A (en) 1999-07-12

Family

ID=22083734

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22064/99A Abandoned AU2206499A (en) 1997-12-23 1998-12-22 Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions

Country Status (2)

Country Link
AU (1) AU2206499A (en)
WO (1) WO1999032443A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20210145787A (en) 2019-04-02 2021-12-02 알리고스 테라퓨틱스 인코포레이티드 Compounds targeting PRMT5

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR73633B (en) * 1980-03-10 1984-03-26 Janssen Pharmaceutica Nv
GB9121631D0 (en) * 1991-10-11 1991-11-27 Nat Res Dev Pharmaceutical compositions
US5691323A (en) * 1995-05-12 1997-11-25 Merck & Co., Inc. Muscarine antagonists
DE19607436A1 (en) * 1996-02-28 1997-09-04 Thomae Gmbh Dr K New carboxylic acid compounds useful e.g. as antiinflammatory or antithrombotic agents

Also Published As

Publication number Publication date
WO1999032443A1 (en) 1999-07-01

Similar Documents

Publication Publication Date Title
AU2307999A (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
AU2206699A (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
AU2111199A (en) Benzenesulfonamides and benzamides as therapeutic agents
AU3185495A (en) Spiro-substituted azacyclic derivatives and their use as therapeutic agents
AU4520697A (en) Use of substituted benzazoles as UV absorbers, new benzazoles and processes for their preparation
AU5842896A (en) Hydrotreating catalyst: composition, preparation, and use thereof
AU3102097A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU3497295A (en) Compositions and methods for the treatment of body weight disorders, including obesity
AU1709699A (en) 13-oxa prostaglandins for the treatment of glaucoma and ocular hypertension
AU1392900A (en) 2,5-diazabicyclo(2.2.1)heptane derivatives, their preparation and therapeutic uses
AU4069395A (en) Optically active benzothiepin derivative, its preparation and use
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
AU2672795A (en) Benzopyrans and their use as therapeutic agents
AU8038998A (en) Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
AU2307899A (en) Muscarinic agents and use thereof to treat glaucoma, myopia and various other conditions
AU3651795A (en) Substituted pyrazolyl-pyrazole derivatives, processes for their preparation and their use as agents with herbicidal action
AU3268197A (en) Spiro-piperidine derivatives and their use as therapeutic agents
AU1714599A (en) Treatment of glc1a glaucoma with glucocorticoid antagonists
AU1249395A (en) Topical treatment of ocular photophobia
AU6714996A (en) 2-(fluorenonyl)-carbapenems, compositions and methods of use
AU2068295A (en) Skin treatment composition
AU2206499A (en) Muscarinic agents and use thereof to treat glaucoma, myopia, and various other conditions
AU2306595A (en) Dihydrodibenzo(de,h)isoquinolines derivatives and their use as anti-cancer agents
AU7759698A (en) Hair treatment agents
AU2434297A (en) The use of 5-ht1b/1d agonists to treat ocular pain

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase